Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …
Research and development partnerships between big pharma and the biotech sector are now a vital component in bringing new medicines …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

